Molecular Dynamics Investigation of MFS Efflux Pump MdfA Reveals an Intermediate State between Its Inward and Outward

Ying Li1, Xizhen Ge1

  • 1College of Biochemical Engineering, Beijing Union University, Beijing 100023, China.

Insights

Understanding how multidrug resistance efflux pumps change shape is key to fighting antibiotic resistance. This study reveals intermediate states in the MdfA efflux pump

Area of Science:

  • Structural Biology
  • Molecular Dynamics
  • Antimicrobial Resistance

Background:

  • Multidrug resistance (MDR) is a significant threat to antibiotic therapy, driven by bacterial efflux pumps.
  • Major Facilitator Superfamily (MFS) efflux pumps, like MdfA from E. coli, are implicated in quinolone resistance.
  • The precise mechanisms of MFS efflux pump conformational transitions, often described by a rocker-switch model, are not fully understood.

Purpose of the Study:

  • To investigate the factors influencing the conformational transition of the MFS efflux pump MdfA.
  • To elucidate the intermediate states and molecular mechanisms underlying MdfA's transport cycle in silico.

Main Methods:

  • Utilized molecular dynamics (MD) simulations to model MdfA's inward and outward conformations.
  • Analyzed subtle differences between simulated states to identify key transition events.
  • Focused on changes in protonation, hydration, structural alterations, and salt bridge dynamics.

Main Results:

  • Identified a distinct intermediate conformational state during MdfA's transition.
  • Conformational change from outward to inward is initiated by periplasmic protonation, promoting hydration and helix 1 alteration.
  • Increased hydrophobic interactions with the membrane store energy for reverse transition; altered cytoplasmic salt bridges facilitate substrate entry.

Conclusions:

  • Detailed the total and local molecular changes during MdfA's conformational transition.
  • Provided insights into the energy storage and release mechanisms governing efflux pump function.
  • Findings offer a basis for designing novel inhibitors targeting MFS efflux pumps to combat antibiotic resistance.

Related Concept Videos

Protein Diffusion in the Membrane01:24

Protein Diffusion in the Membrane

Proteins show rotational as well as lateral diffusion across the membrane. The lateral diffusion of proteins was confirmed through the cell fusion experiment where mouse and human cells were fused, resulting in hybrid cells. When the human and mouse cells fused, the specific membrane proteins on human and mouse cells were marked with the red and green-fluorescent markers, respectively. Initially, the red and green fluorescence was located on the respective hemisphere of the cell. As time...
4.5K
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport01:19

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
4.0K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
490